Predictors of acute myocardial infarction mortality in hypertensive patients treated in primary care

References

• Criqui MH, Barrett-Connor E, Holdbrook MJ, Austin M, Turner JD. Clustering of cardiovascular disease risk factors. Prev Med 1980; 9: 525–33
   PubMed Web of Science ®Google Scholar
• Bøg-Hansen E, Lindblad U, Bengtsson K, Ranstam J, Melander A, Råstam L. Risk factor clustering in patients with hypertension and non-insulin-dependent diabetes mellitus. The Skaraborg Hypertension Project. J Int Med 1998; 243: 223–32
   PubMedGoogle Scholar
• Kannel WB. Status of risk factors and their consideration in antihypertensive therapy. Am J Cardiol 1987; 59: 80A–90A
   PubMed Web of Science ®Google Scholar
• 1999 World Health Organization – International Society of Hypertension. Guidelines for the Management of Hypertension. J Hypertens 1999;17:151–83.
   PubMed Web of Science ®Google Scholar
• 2003 European Society of Hypertension – European Society of Cardiology guidelines for the management of arterial hypertension. Guidelines Committee. J Hypertens 2003;21:1011–53.
   PubMed Web of Science ®Google Scholar
• Swedish Council on Technology Assessment in Health Care. Måttligt förhöjt blodtryck. En systematisk litteraturöversikt [Moderately raised blood pressure. A systematic survey of publications]. SBU-rapport 170; 2004. Stockholm: SBU [SBU, Box 5650, 114 86 Stockholm, Sweden].
   Google Scholar
• Berglund G, Isacsson S-O, Rydén L. The Skaraborg Project – a controlled trial regarding the effect of structured hypertension care. Acta Med Scand 1979; 205[Suppl 626]: 64–8
   Google Scholar
• Rose GA. The diagnosis of ischemic heart pain and intermittent claudication in field surveys. Bull World Health Organ 1962; 27: 645–58
   PubMed Web of Science ®Google Scholar
• Matthews DR, Hosker JP, Rudenski AS, Naylor BA, Treacher DF, Turner RC. Homeostasis model assessment: Insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 1985; 28: 412–19
   PubMed Web of Science ®Google Scholar
• World Health Organization Expert Committee. Diabetes mellitus. Technical Report Series no 742. GenevaSwitzerland: WHO; 1985.
   Google Scholar
• Rose GA, Blackburn H, Gillum RF, Prineas RJ. Cardiovascular Survey Methods2nd edn. World Health Organization, Geneva 1982; 123–29
   Google Scholar
• Lindblad U, Råstam L, Ranstam J, Peterson M. Validity of register data on acute myocardial infarction and acute stroke: The Skaraborg Hypertension Project. Scand J Soc Med 1993; 1: 3–9
   Google Scholar
• Larsson CA, Gullberg B, Merlo J, Råstam L, Lindblad U. Female advantage in AMI mortality is reversed in patients with type 2 diabetes in the Skaraborg Project. Diabetes Care 2005; 28: 2246–8
   PubMed Web of Science ®Google Scholar
• Bøg-Hansen E, Lindblad U, Gullberg B, Melander A, Råstam L. Survival in patients with hypertension treated in primary care: A population-based follow-up study in the Skaraborg Hypertension and Diabetes Project. Scand J Prim Health Care 2004; 22: 222–7
   PubMed Web of Science ®Google Scholar
• Lee WL, Cape D, Cheung A, Zinman B. Impact of diabetes on coronary artery disease in women and men: A meta-analysis of prospective studies. Diabetes Care 2000; 23: 962–8
   PubMed Web of Science ®Google Scholar
• Halimi JM, Forhan A, Balkau B, Novak M, Wilpart E, Tichet J, et al. DESIR Study Group. Is microalbuminuria an integrated risk marker for cardiovascular disease and insulin resistance in both men and women?. Cardiovasc Risk 2001; 8: 139–46
   PubMedGoogle Scholar
• The Scandinavian Simvastatin Survival Study Group. Randomised trial of cholesterol lowering in 4444 patients with coronary heart disease: The Scandinavian Simvastatin Survival Study (4S). Lancet 1994;344:1383–9.
   PubMed Web of Science ®Google Scholar
• Hansson L, Zanchetti A, Carruthers SG, Dahlöf B, Elmfeldt D, Julius S, et al. Effects of intensive blood-pressure lowering and low-dose aspirin in patients with hypertension: Principal results of the Hypertension Optimal Treatment (HOT) randomised trial. Lancet 1998; 351: 1755–62
   PubMed Web of Science ®Google Scholar
• Alberti, KGMM, Zimmet, PZ, for the WHO Consultation. Definition, diagnosis and classification of diabetes mellitus and its complications, Part 1: Diagnosis and classification of diabetes mellitus. Provisional report of a WHO consultation. Diabet Med 1998;15:539–53.
   PubMed Web of Science ®Google Scholar
• Nilsson P, Theobald H, Journath G, Fritz T. Gender differences in risk factor control and treatment profile in diabetes: A study in 229 Swedish primary heath care centres. Scand J Prim Health Care 2004; 22: 27–31
   PubMed Web of Science ®Google Scholar
• Kjellgren KI, Ahlner J, Dahlöf B, Gill H, Hedner T, Säljö R. Perceived symptoms amongst hypertensive patients in routine clinical practice – a population-based study. J Intern Med 1998; 244: 325–32
   PubMed Web of Science ®Google Scholar
• Wolf-Maier K, Cooper RS, Kramer H, Banegas JR, Giampaoli S, Joffres MR, et al. Hypertension treatment and control in five European countries, Canada, and the United States. Hypertension 2004; 43: 10–7
   PubMed Web of Science ®Google Scholar
• Hedblad B, Nerbrand C, Ekesbo R, Johansson L, Midlöv P, Brunkstedt I, et al. High blood pressure despite treatment: Results from a cross-sectional primary healthcare-based study in southern Sweden. Scand J Prim Health Care 2006; 24: 224–30
   PubMed Web of Science ®Google Scholar
• Bøg-Hansen E, Lindblad U, Gullberg B, Melander A, Råstam L. Metabolic disorders associated with uncontrolled hypertension: The Skaraborg Hypertension and Diabetes Project. Diabetes Obes Metab 2003; 5: 379–87
   PubMed Web of Science ®Google Scholar
• Kvenild K, Romundstad S, Midthjell K, Kruger Ö, Hallan H, Holmen J. Microalbuminuria in treated hypertensives: Only a mirror image of cardiovascular risk?. Scand J Prim Health Care 2006; 24: 145–53
   PubMed Web of Science ®Google Scholar
• Juutilainen A, Kortelainen S, Lehto S, Rönnemaa T, Pyörälä K, Laakso M. Gender difference in the impact of type 2 diabetes on coronary heart disease risk. Diabetes Care 2004; 27: 2898–904
   PubMed Web of Science ®Google Scholar
• Ferrara A, Williamson DF, Karter AJ, Thompson TJ, Kim X. Sex differences in quality of health care related to ischemic heart disease prevention in patients with diabetes. Diabetes Care 2004; 27: 2974–6
   PubMedGoogle Scholar
• Barret-Connor EL, Cohn BA, Wingard DL, Edelstein S. Why is diabetes mellitus a stronger risk factor for fatal ischemic heart disease in women than in men? The Rancho Bernado Study. JAMA 1991; 265: 627–31
   PubMedGoogle Scholar
• Gaede P, Vedel P, Parving H-H, Pedersen O. Intensified multifactorial intervention in patients with type 2 diabetes mellitus and microalbuminuria: The Steno type 2 randomised study. Lancet 1999; 353: 617–22
   PubMed Web of Science ®Google Scholar
• Agevall S, Fagerberg B, Berglund G, Schmidt C, Wendelhag I, Wikstrand J. for the Risk Factor Intervention Group, Sweden. Multiple risk intervention trial in high risk hypertensive men: comparison of ultrasound intima-media thickness and clinical outcome during 6 years follow-up. J Intern Med 2001; 249: 305–14
   PubMedGoogle Scholar